Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | HALO | TGTX | ||
| Company | Verona Pharma Plc ADR | Halozyme Therapeutic | Tg Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 72.96 | 53.97 | ||
| High | 106.93 | 76.32 | 56.74 | ||
| Low | 106.81 | 72.71 | 53.68 | ||
| Latest | 106.91 | 74.96 | 55.83 | ||
| Change | +0.12 | +2.32 | +2.20 | ||
| % Change | +0.11% | +3.20% | +4.10% | ||
| Volume | 1,871,900 | 2,872,400 | 6,852,200 | ||
| 20-Day Average Volume | 1,504,320 | 1,888,500 | 3,058,755 | ||
| Previous Close | 106.79 | 72.64 | 53.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 70.11 | 46.91 | ||
| 20-Day Raw Stochastic | 98.26% | 87.32% | 92.60% | ||
| 20-Day Relative Strength | 70.52 | 63.19 | 79.18 | ||
| Weighted Alpha | +201.62 | +37.44 | +75.41 | ||
| Today's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | +9.35% since 06/18/26 | +4.90% since 06/18/26 | ||
| Low | 106.61 on 09/30/25 | 68.27 on 06/22/26 | 52.70 on 06/23/26 | ||
| High | 106.93 on 10/06/25 | 76.32 on 06/26/26 | 57.38 on 06/22/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | +9.08% since 05/26/26 | +40.52% since 05/26/26 | ||
| Low | 105.78 on 09/19/25 | 65.60 on 06/02/26 | 36.47 on 06/02/26 | ||
| High | 106.93 on 10/06/25 | 76.32 on 06/26/26 | 57.38 on 06/22/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +18.44% since 03/26/26 | +74.58% since 03/26/26 | ||
| Low | 86.63 on 07/08/25 | 61.33 on 03/27/26 | 31.31 on 03/27/26 | ||
| High | 106.93 on 10/06/25 | 76.32 on 06/26/26 | 57.38 on 06/22/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +8.84% since 12/26/25 | +81.44% since 12/26/25 | ||
| Low | 47.20 on 04/07/25 | 61.33 on 03/27/26 | 26.76 on 03/12/26 | ||
| High | 106.93 on 10/06/25 | 82.22 on 02/09/26 | 57.38 on 06/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 8,891,230 | 8,546,679 | ||
| Shares Outstanding, K | 81,830 | 118,613 | 153,084 | ||
| Annual Sales | 42,280,000 | 1,396,610,000 | 616,290,000 | ||
| Annual Net Income | -173,420,000 | 316,890,000 | 447,180,000 | ||
| Last Quarter Sales | 103,140,000 | 376,710,000 | 204,920,000 | ||
| Last Quarter Net Income | 11,920,000 | 150,050,000 | 19,780,000 | ||
| 60-Month Beta | 0.05 | 0.88 | 1.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | 1.60 on 05/11/26 | 0.17 on 05/06/26 | ||
| Earnings Date | 11/03/25 | 08/04/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.17 | 18.43 | ||